A cohort study conducted in Karachi in 2010-12 compared the fetomaternal outcomes in patients diagnosed with GDM receiving insulin therapy or metformin and concluded that metformin yielded a better impact on feto-maternal outcomes and glycemic control in comparison to Insulin therapy provided with both less maternal increase in weight and NICU admissions [11]. This evidence concerns the gene INS and gestational diabetes.